MAUREEN COPELAND: Open Payments
NPI 1235624057 · W SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 7 payments from 7 companies in 2025. Trend: 2023 $76 · 2024 $159 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $122 |
| Novo Nordisk Inc | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| ViiV Healthcare Company | 1 | $26 |
| Hologic Sales and Service, LLC | 1 | $26 |
| QIAGEN, LLC | 1 | $23 |
| PFIZER INC. | 1 | $21 |
Products named: Epclusa, Wegovy, AREXVY, APRETUDE, APTIMA, ELIQUIS.
Industry payments across CA — which companies pay providers there.
